ArticlePloS one2017

Phosphatidlyinositol-3-kinase C2 beta (PI3KC2β) is a potential new target to treat IgE mediated disease.

Shekhar Srivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.